Published in Case Rep Med on June 30, 2010
From portal to splanchnic venous thrombosis: What surgeons should bear in mind. World J Hepatol (2014) 0.77
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation. World J Surg (2009) 3.47
Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant (2006) 1.29
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation (1998) 1.28
Cavoportal hemitransposition for the simultaneous thrombosis of the caval and portal systems - a review of the literature. Ann Hepatol (2008) 0.89
Eversion thromboendovenectomy for organized portal vein thrombosis encountered during liver transplantation. Transplant Proc (2003) 0.87
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation. World J Surg (2009) 3.47
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl (2004) 1.66
Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl (2003) 1.61
Retracted Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc Natl Acad Sci U S A (2013) 1.59
Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation (2003) 1.46
Herpes simplex in a liver transplant recipient. Liver Transpl (2006) 1.39
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl (2003) 1.31
Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl (2008) 1.19
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl (2008) 1.18
A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl (2002) 1.08
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl (2011) 1.06
Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: an analysis of the literature. J Transplant (2010) 1.02
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant (2005) 1.02
Atrial septal perforation from TIPS stent migration. J Vasc Interv Radiol (2004) 1.00
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab (2012) 0.91
Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant (2004) 0.90
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol (2013) 0.90
Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. Hepatology (2013) 0.88
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl (2003) 0.88
May-Thurner syndrome complicating left-sided renal transplant. Transplantation (2010) 0.88
Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int (2007) 0.86
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl (2003) 0.85
Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl (2008) 0.85
Reduced use of intensive care after liver transplantation: influence of early extubation. Liver Transpl (2002) 0.84
Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg (2008) 0.82
Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg (2015) 0.82
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Transplant tourism and unregulated black-market trafficking of organs. Am J Transplant (2009) 0.80
Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Liver Transpl (2002) 0.80
Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases. Transplantation (2008) 0.79
Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation (2009) 0.78
Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma. Expert Opin Pharmacother (2007) 0.78
Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards. Liver Transpl (2002) 0.78
Pediatric liver transplantation. Curr Opin Pediatr (2004) 0.77
Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava. Liver Transpl (2004) 0.76
A Decade of Experience Using mTor Inhibitors in Liver Transplantation. J Transplant (2011) 0.76
The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clin Transplant (2010) 0.76
Direct Anastomosis of the Donor Hepatic Artery to the Supraceliac Aorta without Extension Graft during Adult Liver Transplant in the Era of Extended Criteria Donors: Report of a Case. Case Rep Med (2010) 0.75
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant (2013) 0.75
Choledochoduodenostomy in pediatric liver transplantation. Pediatr Transplant (2011) 0.75
Hepatic artery pseudoaneurysm - duodenal fistula after living donor liver transplant. Clin Transplant (2004) 0.75
Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis. Am J Med Sci (2007) 0.75
Bariatric surgery in liver transplant patients: weighing the evidence. Obes Surg (2008) 0.75
Hepatic hemodynamics and portal flow modulation: The A2ALL experience. Transplantation (2017) 0.75